PANEL DISCUSSION: SCREENING FOR LUNG CANCER. Anthony D Weaver MD

Similar documents
LUNG CANCER SCREENING: LUNG CANCER SCREENING: THE TIME HAS COME LUNG CANCER: A NATIONAL EPIDEMIC

LUNG CANCER SCREENING

Criteria USPSTF CMS. Frequency Annual screening Annual screening. No signs or symptoms of lung cancer

Lung Cancer Screening: Current Status

Lung Cancer Screening:

Advancing Health Equity in Lung Cancer Outcomes

Disclosures. Overview. Selection the most accurate statement: Updates in Lung Cancer Screening 5/26/17. No Financial Disclosures

LDCT Screening. Steven Kirtland, MD. Virginia Mason Medical Center February 27, 2015

Lung Cancer Screening: Benefits and limitations to its Implementation

Goals of Presentation

Faculty Disclosure. Objectives. Lung Cancer in Kentucky: Improving Patient Outcomes 10/28/16. Lung Cancer Burden in Kentucky

Lung Cancer Screening: To screen or not to screen?

Screening for Lung Cancer - State of the Art

MEDICAL POLICY SUBJECT: LOW-DOSE COMPUTED TOMOGRAPHY (LDCT) FOR LUNG CANCER SCREENING. POLICY NUMBER: CATEGORY: Technology Assessment

Lung Cancer Screening

Lung Cancer Screening

Screening for Lung Cancer: New Guidelines, Old Problems

Lung Cancer Screening. Eric S. Papierniak, DO NF/SG VHA UF Health

Lung Cancer Screening

SHARED DECISION MAKING AND LUNG CANCER SCREENING

An Update on Lung Cancer Screening Policy and the Role of Quitlines

Lung Cancer Screening: To Screen or Not to Screen?

Screening Programs background and clinical implementation. Denise R. Aberle, MD Professor of Radiology and Engineering

What to know and what to make of it

Christine Argento, MD Interventional Pulmonology Emory University

LUNG CANCER: LDCT DISCLOSURES NONE. Erika Swanson, MD Radiation Oncologist Ascension Columbia-St. Mary s February 1, /9/2018

Low-Dose CT Cancer Screening Program

Cancer Screenings and Early Diagnostics

SHARED DECISION MAKING IN MEDICARE COVERAGE

LUNGS? YOU GET THESE YOUR GUIDE TO YEARLY LUNG CANCER SCREENING CHECKED REGULARLY. WHAT ABOUT YOUR. Think. Screen. Know.

American Medical Association Journal of Ethics

CLINICAL GUIDELINES. Lung-Cancer Screening Program Guidelines Robert Y. Kanterman, M.D. and Thomas J. Gilbert, M.D., M.P.P.

Updates In Cancer Screening: Navigating a Changing Landscape

Current Approach to Screening for Lung Cancer. James R Jett M.D.

Example of lung screening

LUNG CANCER SCREENING COVERAGE IN STATE MEDICAID PROGRAMS

A Summary from the 2013World Conference on Lung Cancer Sydney, Australia

SCREENING FOR EARLY LUNG CANCER. Pang Yong Kek

2018 Community Outreach Report

Decoding the USPSTF. By: Dr Vikram Arora Heritage Valley Health System

Charles Mulligan, MD, FACS, FCCP 26 March 2015

VHA Demonstration Project for Lung Cancer Screening Using Low-Dose Chest CT Screening

Page 1. Cancer Screening for Women I have no conflicts of interest. Overview. Breast, Colon, and Lung Cancer. Jeffrey A.

The status of Lung Cancer Screening Guidelines. Peter B. Bach, MD, MAPP Memorial Sloan Kettering Cancer Center

DOH LUNG CANCER SCREENING SERVICE SPECIFICATIONS

A Comprehensive Cancer Center Designated by the National Cancer Institute

Lung Cancer Screening

Lung Cancer Screening Who, When, Why

Lung Cancer Screening In High Risk Populations:

Patient Decision Aid. Summary Guide for Clinicians. Clinician s Checklist

Cancer Screening 2009: New Tests, New Choices

Emerging Challenges in Primary Care: Lung Cancer Screening: Who, When, Why Or Why Not? Objectives. Faculty

New Advances in Lung Cancer

LUNG CANCER SCREENING: ON WHOM DID YOU DO IT AND ON WHOM DO YOU RESPOND TO THE RESULTS?

Lung Cancer Screening: Who, What, Why? Myths Dispelled

Selected Controversies. Cancer Screening. Breast Cancer Screening. Selected Controversies. Page 1. Using Best Evidence to Guide Practice

None

Page 1. Selected Controversies. Cancer Screening! Selected Controversies. Breast Cancer Screening. ! Using Best Evidence to Guide Practice!

DISCLOSURE. Lung Cancer Screening: The End of the Beginning. Learning Objectives. Relevant Financial Relationship(s) Off Label Usage

The complex, intertwined role of patients in research and care

Lung Cancer Screening: Radiologic and Clinical Implications. Katherine R. Birchard, M.D. University of North Carolina at Chapel Hill

Lung Cancer screening :

Master Class: Fundamentals of Lung Cancer

Screening for Lung Cancer. Michael S. Nolledo, MD Deborah Heart and Lung Center

Ann Intern Med. 2012;156(5):

Lung Cancer Screening

The Challenge of Cancer Screening Part One Prostate Cancer and Lung Cancer Screening

Richard M. Hoffman, MD, MPH University of Iowa Carver College of Medicine Holden Comprehensive Cancer Center

Lung Cancer Screening Benefits, Risks & Challenges

Robert J. McKenna M.D. Chief, Thoracic Surgery Cedars Sinai Medical Center

Lung Cancer Screening

Learning Objectives. 1. Identify which patients meet criteria for annual lung cancer screening

Epidemiology of Lung Cancer: Implications for screening and prevention

Recommendations on Screening for Lung Cancer 2016

Lung Cancer in Women: A Different Disease? James J. Stark, MD, FACP

Guidelines for the Early Detection of Cancer

Objectives. Why? Why? Background 11/5/ % incurable disease at presentation Locally advanced disease Metastasis. 14% 5 year survival

Lung Cancer Screening: Evidence and current recommendations

Cancer Screening & Prevention. Dr. Jamey Burton, MD, FAAFP

The National Lung Screening Trial (NLST)

Evidence-based Cancer Screening & Surveillance

Page 1. Controversies in Cancer Prevention and Screening. Disclosures. Screening. Principles of Screening. I have no conflicts of interest

CT Screening for Lung Cancer for High Risk Patients

Epidemiology of Lung Cancer: Implications for screening and prevention

Lung Cancer Screening Trials. Edward Harris Respiratory Research Fellow Sir Charles Gairdner Hospital

Lung cancer Screening

2015 Annual Report Lung Screening

An Educational Toolkit to Promote Lung Cancer Screening in Primary Care

Lung Cancer Screening. Ashish Maskey MD Interventional Pulmonology UK Health Care Dec 1 st 2017

WELLNESS INITIATIVE NOW

Introduction and Background

National Cancer Institute

Cancer in Maine: Using Data to Direct Actions 2018 Challenge Cancer Conference May 1, 2018

Role of CT in Lung Cancer Screening: 2010 Stuart S. Sagel, M.D.

Cancer in PA: Radon Awareness. Welcome. Thank you for joining us. The webinar will begin soon. #PACancerTrends

LUNG NODULES: MODERN MANAGEMENT STRATEGIES

Veterans Health Administration Lung Cancer Screening Demonstration Project: Results & Lessons Learned

Colorectal Cancer Screening

University of Connecticut. University of Connecticut Graduate School

Adam J. Hansen, MD UHC Thoracic Surgery

Transcription:

PANEL DISCUSSION: SCREENING FOR LUNG CANCER Anthony D Weaver MD

Disclosures Anthony Weaver has no relationships to disclose. Thank God! A panel of experts! An Equal Opportunity University

Objectives 1. Analyze the current demographics of lung cancer in Kentucky. 2. Discuss current guidelines and recommendations for lung cancer screening 3. Review selected research on lung cancer screening 4. Suggest future directions An Equal Opportunity University

Objective 1 Analyze the current demographics of lung CA

Statistics: lung cancer leading cause of cancer deaths in the US In 2012, there were more than 225 000 new cases and more than 160,000 deaths Lung cancer deaths surpassed the total deaths from cancers of the breast, prostate, and colon combined.1 An Equal Opportunity University

Lung Cancer, 2004-2008 Region Incidence Rate Mortality Rate US* 62.0 52.5 # Kentucky** 100.8 75.1 The KY incidence is 62.6% HIGHER than the US The KY mortality is 43.0 % HIGHER than the US An Equal Opportunity University *Source: SEER*Stat 7.0.4 SEER 17 Registries **Source: Kentucky Cancer Registry #: Based on 2003-2007 rate

Kentucky Cancer Deaths per year 2006-2010 Lung and Bronchus 3416 Colon 881 Breast 597 Pancreas 507 Prostate 392 Leukemia 332 Non-Hodgkin Lymphoma 320 Ovary 212 An Equal Opportunity University

Lung/Bronchus Cancer All 120 counties death rate above the US average. The death rate varies from 59 in Larue and Cumberland counties to 124 in Gallatin County. The highest rates are in eastern KY and Ohio, Butler, and Muhlenberg counties. An Equal Opportunity University

Smoking 90% of lung cancer related to smoking. The strongest determinant of lung cancer in smokers is duration of cigarette smoking, and the risk also becomes larger with the number of cigarettes smoked. Smoking causes lung cancer in both men and women. An Equal Opportunity University

Prevalence of Current Smoking by Area Development District, 2010 An Equal Opportunity University

Lung Cancer Incidence by Area Development District, 2004-2008 An Equal Opportunity University

Lung Cancer Mortality by Area Development District, 2004-2008 An Equal Opportunity University

Other Risk Factors Radiation therapy in both Hodgkin lymphoma and breast cancer. Environmental toxins: second-hand smoke, asbestos, radon, metals (arsenic, chromium, and nickel), ionizing radiation, and polycyclic aromatic hydrocarbons. Pulmonary fibrosis risk increased about 7X HIV infection Genetic factors clearly established familial risk. Dietary factors (antioxidants, cruciferous vegetables, phytoestrogens) may reduce the risk of lung cancer, but trials in high-risk patients have not been successful. An Equal Opportunity University

Radon? An Equal Opportunity University

Lung Cancer in the Mountains

ilovemountains.org

Objective 2 Discuss current guidelines and recommendations for lung cancer screening

USPSTF The USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery. (B recommendation) An Equal Opportunity University

On April 30, 2014, the Centers for Medicare & Medicaid Services (CMS) will be convening a Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) meeting to review all the available data, prior to making its final coverage decision.

From: Computed Tomography Screening for Lung Cancer JAMA. 2013;309(11):1163-1170. doi:10.1001/jama.2012.216988 Figure Legend: Date of download: 3/25/2013 Copyright 2012 American Medical Association. All rights reserved.

AAFP (2013) The evidence is insufficient to recommend for or against screening (Grade: I recommendation) AAFP has significant concern with basing such a far reaching and costly recommendation on a single study. The NLST, conducted in major medical centers, has not been replicated in a community setting. The long term harms of radiation exposure unknown. An Equal Opportunity University

AAFP (2013) The USPSTF recommends annual CT screening even though the NLST trial was only 3 scans NNS to prevent one lung cancer death over 5 years and 3 screenings is 312. NNS to prevent one death by any cause is 208 over 5 years in the NLST trial. 40% will have a positive result requiring follow-up. The harms of these follow-up interventions in the community is not known. "The cost-effectiveness of low-dose CT screening must also be considered in the context of competing interventions, particularly smoking cessation." An Equal Opportunity University

Objective 3 Review selected research on lung cancer screening

MDLCP Entry Criteria An Equal Opportunity University

Screening LCST: Three yearly screenings with either low dose CT or PA/Lat CXRs and followed for 3.5 years MDLCP: Three yearly screenings with low dose CT at community hospitals, with central review An Equal Opportunity University

Problems with Community-based screening Variability in the interpretation screening CT by local radiologists with the discrepancy rate of 9% and 3/6 cancers initially missed In patients with nodules: Recommendations from local radiologist may vary from Fleischner guidelines Inconsistency by referring physicians in following recommendations An Equal Opportunity University

Date of download: 4/15/2014 Copyright American College of Chest Physicians. All rights reserved. Evaluation of Patients With Pulmonary Nodules: When Is It Lung Cancer? * : ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest. 2007;132(3_suppl):108S-130S. doi:10.1378/chest.07-1353 Fleischner Society Guidelines

Current Practice on F/U of nodules JAMA Intern Med. Published online April 7, 2014. An Equal Opportunity University

Too Much and Too Little Care Reviewed records of 300 adults with pulmonary nodules from 15 VA s 20% 4 mm 45% 5-8 mm 36% > 8 mm Median # of tests =2 (benign nodule), 8 (cancer) Median total F/U = 13 mo. (<1mo.-8.5 yrs) 4/13 nodules resected were benign 8/46 with invasive testing had complications An Equal Opportunity University

Conclusions 55.3% of patients received appropriate evaluation, 17.8% over-evaluated, and 26.9% under-evaluated. "It is important for clinicians to recognize that there is a real gap between care that is currently being delivered to patients with pulmonary nodules and what clinical practice guidelines considered optimal care" An Equal Opportunity University

JAMA May 20, 2012, Vol 307, No. 22

Conclusion Screening a population of individuals at a substantially elevated risk of lung cancer most likely could be performed in a manner such that the benefits that accrue to a few individuals outweigh the harms that many will experience. However, there are substantial uncertainties regarding how to translate that conclusion into clinical practice. An Equal Opportunity University

Lung Cancer: Why the Guilt Trip? Memorial Sloan-Kettering survey 2000 lung cancer patients 84% current non-smokers people who start smoking are generally 12 or 13years old They were targeted. We are going to be faced with an epidemic of lung cancer for a decade or more if every single person stops smoking today. An Equal Opportunity University

Objective 4 Suggest future directions

SUGGESTIONS We should be screening for lung cancer in Kentucky, particularly Eastern Kentucky Scans should be done locally, with oversight There should be at a minimum a registry, but preferably an organized network for managing positive screens Talk to Whitney Jones about starting a statewide cancer screening program An Equal Opportunity University

Weaver s wish list Statewide smoking ban $.50 per pack increase in state cigarette tax Kentucky Medicaid pays for lung cancer screening, but demands accountability Lung cancer biospecimen bank with statewide specimen collection Research into the determinants of lung cancer in high risk counties (?Mountain Top Removal?) An Equal Opportunity University